UPM to Manufacture Products For Amerigen Pharmaceuticals

April 23, 2014
Melanie Sena

Melanie Sena is community editor of Pharmaceutical Technology.

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management-05-07-2014, Volume 10, Issue 5

UPM will commercially manufacture two ANDA products for Amerigen Pharmaceuticals.

UPM, a division of Gregory Pharmaceutical Holdings, has reached an agreement with Amerigen Pharmaceuticals, to commercially manufacture two ANDA products for a 10-year supply term. In addition, the agreement allows for UPM to develop and potentially commercially supply several additional ANDA products for Amerigen over the next few years. UPM acquired a 475,000 ft2 Pfizer manufacturing facility in Bristol, Tennessee in July of 2013, that will supply these products.

Source: UPM

Related Content:

Bio/Pharma Business